BMY
Bristol-Myers Squibb Company · Healthcare
EVP and CFO David Elkins V sold $1.9M of Bristol-Myers Squibb Company
Sold$1,850,016
$61.67Price
30,000Shares
−16%Stake
What BMY did after the filing
- The stock from Thu, Apr 2 close, $59.60
- −4.4%
- S&P 500, same days
- +12.7%
Measured over 30 trading days, to the May 15 close.
Traded Wed, Apr 1. Filed Thu, Apr 2, 12:29 PM ET, during the session. Returns use the Apr 2 close and the May 15 close. Not investment advice.